动脉动脉粥状硬化斑块切除术器械市场规模、份额和成长分析(按产品、应用、最终用户和地区划分)—产业预测(2026-2033 年)
市场调查报告书
商品编码
1895975

动脉动脉粥状硬化斑块切除术器械市场规模、份额和成长分析(按产品、应用、最终用户和地区划分)—产业预测(2026-2033 年)

Atherectomy Devices Market Size, Share, and Growth Analysis, By Product (Directional Atherectomy Devices, Orbital Atherectomy Devices), By Application (Peripheral Vascular, Cardiovascular), By End User, By Region - Industry Forecast 2026-2033

出版日期: | 出版商: SkyQuest | 英文 186 Pages | 商品交期: 3-5个工作天内

价格
简介目录

全球动脉粥状硬化斑块切除术设备市场规模预计在 2024 年达到 11.2 亿美元,从 2025 年的 12.2 亿美元成长到 2033 年的 22.7 亿美元,在预测期(2026-2033 年)内复合年增长率为 8.1%。

全球心血管疾病盛行率的不断上升预计将显着推动对动脉动脉粥状硬化斑块切除术器械的需求。人口老化、不健康的生活方式和饮食习惯等因素共同导致心血管疾病发生率上升,加剧了这种需求成长。此外,微创手术日益受到青睐,预计将为动脉粥状硬化斑块切除术器械供应商带来新的发展机会。对医疗研发的投资有望推动该领域的技术进步,创造更多成长机会。然而,动脉粥状硬化斑块切除术手术的高成本、潜在併发症以及替代治疗方法的存在等挑战,可能会在长期内阻碍市场扩张。总而言之,动脉粥状硬化斑块切除术器械市场既蕴藏着巨大的发展机会,也面临许多挑战。

全球动脉动脉粥状硬化斑块切除术器械市场驱动因素

随着老化社会的加剧,心血管疾病(尤其是动脉阻塞)的盛行率不断上升,这成为推动动脉粥状硬化斑块切除术器械需求成长的主要因素。老年人寻求有效的治疗方法,使得先进的医疗干预措施变得至关重要。此外,老年患者越来越倾向于选择微创动脉动脉粥状硬化斑块切除术术,这有助于改善他们的康復和舒适度。这一趋势不仅凸显了动脉粥状硬化斑块切除术器械在心血管疾病管理中的重要性,也表明随着医疗服务提供者不断调整以满足老年患者的需求,动脉粥状硬化斑块切除术器械市场潜力巨大,有望推动该行业未来的增长。

限制全球动脉动脉粥状硬化斑块切除术硬化切除器械市场的因素

动脉粥状硬化斑块切除术术中潜在的併发症对全球动脉动脉粥状硬化斑块切除术器械市场构成重大障碍。由于多种因素相互交织,有效管理每个环节往往极具挑战性,导致固有风险无法完全消除。对这些手术安全性的不确定性可能导致医护人员和患者都持谨慎态度,最终阻碍动脉动脉粥状硬化斑块切除术器械的成长和销售。随着医学界权衡风险和效益,这种疑虑可能会减缓市场成长,并影响该行业的整体产生收入。

全球动脉粥状硬化斑块切除术器械市场趋势

全球动脉粥状硬化斑块切除术器械市场正呈现出显着的趋势,即整合先进技术,尤其是人工智慧 (AI) 和机器学习。製造商正利用这些创新来提升器材的功能和精准度,最终改善病患的治疗效果。透过整合先进的分析技术和自动化流程,企业可以简化研发和部署流程,提高治疗的效率和效果。这种技术革新不仅带来了竞争优势,也透过满足日益增长的、对更先进、更有效的介入心臟病学的需求,拓展了业务机会。因此,在技术进步的驱动下,预计该市场未来将迎来显着成长。

目录

介绍

  • 调查目标
  • 市场定义和范围

调查方法

  • 调查过程
  • 二手资料和一手资料方法
  • 市场规模估算方法

执行摘要

  • 全球市场展望
  • 主要市场亮点
  • 细分市场概览
  • 竞赛概况

市场动态与展望

  • 总体经济指标
  • 驱动因素和机会
  • 限制与挑战
  • 供给面趋势
  • 需求面趋势
  • 波特的分析和影响

关键市场考察

  • 关键成功因素
  • 影响市场的因素
  • 关键投资机会
  • 生态系测绘
  • 市场吸引力指数(2025)
  • PESTEL 分析
  • 价值链分析
  • 定价分析
  • 案例研究
  • 监管环境
  • 技术评估

全球动脉粥状硬化斑块切除术器械市场规模(按产品和复合年增长率划分)(2026-2033 年)

  • 定向斑块动脉粥状硬化斑块切除术装置
  • 轨道动脉动脉粥状硬化斑块切除术装置
  • 光消融动脉粥状斑块动脉粥状硬化斑块切除术装置
  • 旋转式动脉粥状硬化斑块切除术装置
  • 支援的设备
  • 其他的

全球动脉粥状硬化斑块切除术器械市场规模(按应用及复合年增长率划分)(2026-2033 年)

  • 週边血管
  • 心血管系统
  • 神经血管

全球动脉粥状硬化斑块切除术器械市场规模(按最终用户划分)及复合年增长率(2026-2033 年)

  • 医院和诊所
  • 门诊治疗中心
  • 研究机构和学术机构
  • 其他的

全球动脉粥状硬化斑块切除术器械市场规模及复合年增长率(2026-2033)

  • 北美洲
    • 美国
    • 加拿大
  • 欧洲
    • 德国
    • 西班牙
    • 法国
    • 英国
    • 义大利
    • 其他欧洲地区
  • 亚太地区
    • 中国
    • 印度
    • 日本
    • 韩国
    • 亚太其他地区
  • 拉丁美洲
    • 墨西哥
    • 巴西
    • 其他拉丁美洲地区
  • 中东和非洲
    • 海湾合作委员会国家
    • 南非
    • 其他中东和非洲地区

竞争资讯

  • 前五大公司对比
  • 主要企业的市场定位(2025 年)
  • 主要市场参与者所采取的策略
  • 近期市场趋势
  • 公司市占率分析(2025 年)
  • 主要企业公司简介
    • 公司详情
    • 产品系列分析
    • 依业务板块进行公司股票分析
    • 2023-2025年营收年比比较

主要企业简介

  • Medtronic Plc(Ireland)
  • Boston Scientific Corporation(USA)
  • Cardiovascular Systems, Inc.(USA)
  • Royal Philips(Netherlands)
  • Avinger, Inc.(USA)
  • Terumo Corporation(Japan)
  • AngioDynamics, Inc.(USA)
  • Braun Group(Germany)
  • Abbott Laboratories(USA)
  • B. Braun Melsungen AG(Germany)
  • Biotronik SE & Co. KG(Germany)
  • Biomerics(USA)
  • Philips(Netherlands)
  • Cook Medical, Inc.(USA)
  • Cardinal Health, Inc.(USA)
  • Rex Medical, LP(USA)
  • WL Gore & Associates, Inc.(USA)
  • Minnetronix, Inc.(USA)
  • Merit Medical Systems, Inc.(USA)
  • NexStep Medical(USA)

结论与建议

简介目录
Product Code: SQMIG35A2953

Global Atherectomy Devices Market size was valued at USD 1.12 Billion in 2024 and is poised to grow from USD 1.22 Billion in 2025 to USD 2.27 Billion by 2033, growing at a CAGR of 8.1% during the forecast period (2026-2033).

The growing prevalence of cardiovascular disorders globally is anticipated to significantly drive the demand for atherectomy devices. This surge is influenced by an aging population, unhealthy lifestyle choices, and dietary habits, all contributing to a higher incidence of cardiovascular conditions. Additionally, the increasing preference for minimally invasive procedures is expected to open new avenues for atherectomy device providers. Investment in medical research and development is likely to result in technological advancements within this sector, creating further opportunities for growth. However, challenges such as the high costs associated with atherectomy procedures, the potential for complications, and the availability of alternative treatments could hinder market expansion in the long term. Overall, the atherectomy devices market presents both dynamic opportunities and notable challenges.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Atherectomy Devices market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Atherectomy Devices Market Segments Analysis

Global Atherectomy Devices Market is segmented by Product, Application, End User and region. Based on Product, the market is segmented into Directional Atherectomy Devices, Orbital Atherectomy Devices, Photo-Ablative Atherectomy Devices, Rotational Atherectomy Devices, Support Devices, and Others. Based on Application, the market is segmented into Peripheral Vascular, Cardiovascular, and Neurovascular. Based on End User, the market is segmented into Hospitals & Clinics, Ambulatory Care Centers, Research Laboratories & Academic Institutes, and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & and Africa.

Driver of the Global Atherectomy Devices Market

The increasing prevalence of cardiovascular issues, notably arterial blockages, among the aging population significantly drives the demand for atherectomy devices. As more elderly individuals seek effective treatments for these conditions, the necessity for advanced medical interventions becomes paramount. Additionally, there is a noticeable shift toward minimally invasive atherectomy procedures favored by geriatric patients, which enhances patient recovery and comfort. This trend not only highlights the importance of atherectomy devices in managing cardiovascular diseases but also underscores a growing market potential as healthcare providers adapt to meet the needs of this demographic, thereby fostering future growth in the atherectomy devices sector.

Restraints in the Global Atherectomy Devices Market

The potential for complications during atherectomy procedures poses a significant barrier in the global atherectomy devices market. Given the various factors at play, managing each aspect effectively is often unfeasible, leading to an inherent risk that cannot be entirely mitigated. This uncertainty surrounding the safety of such procedures may result in a cautious approach from healthcare professionals and patients alike, ultimately hindering the growth and sales of atherectomy devices. As the medical community weighs the benefits against the risks, this skepticism could contribute to a slowdown in market expansion, affecting overall revenue generation in the sector.

Market Trends of the Global Atherectomy Devices Market

The Global Atherectomy Devices market is witnessing a significant trend towards the integration of advanced technologies, particularly artificial intelligence and machine learning. Manufacturers are leveraging these innovations to enhance the functionality and precision of their devices, ultimately improving patient outcomes. By incorporating advanced analytics and automated processes, companies can streamline development and deployment, fostering greater efficiency and effectiveness in treatment. This technological evolution not only captures a competitive edge but also expands business potential by meeting the growing demand for more sophisticated and effective cardiovascular interventions. As such, the future of the market is poised for substantial growth driven by technological advancement.

Table of Contents

Introduction

  • Objectives of the Study
  • Market Definition & Scope

Research Methodology

  • Research Process
  • Secondary & Primary Data Methods
  • Market Size Estimation Methods

Executive Summary

  • Global Market Outlook
  • Key Market Highlights
  • Segmental Overview
  • Competition Overview

Market Dynamics & Outlook

  • Macro-Economic Indicators
  • Drivers & Opportunities
  • Restraints & Challenges
  • Supply Side Trends
  • Demand Side Trends
  • Porters Analysis & Impact
    • Competitive Rivalry
    • Threat of Substitute
    • Bargaining Power of Buyers
    • Threat of New Entrants
    • Bargaining Power of Suppliers

Key Market Insights

  • Key Success Factors
  • Market Impacting Factors
  • Top Investment Pockets
  • Ecosystem Mapping
  • Market Attractiveness Index, 2025
  • PESTEL Analysis
  • Value Chain Analysis
  • Pricing Analysis
  • Case Studies
  • Regulatory Landscape
  • Technology Assessment

Global Atherectomy Devices Market Size by Product & CAGR (2026-2033)

  • Market Overview
  • Directional Atherectomy Devices
  • Orbital Atherectomy Devices
  • Photo-Ablative Atherectomy Devices
  • Rotational Atherectomy Devices
  • Support Devices
  • Others

Global Atherectomy Devices Market Size by Application & CAGR (2026-2033)

  • Market Overview
  • Peripheral Vascular
  • Cardiovascular
  • Neurovascular

Global Atherectomy Devices Market Size by End User & CAGR (2026-2033)

  • Market Overview
  • Hospitals & Clinics
  • Ambulatory Care Centers
  • Research Laboratories & Academic Institutes
  • Others

Global Atherectomy Devices Market Size & CAGR (2026-2033)

  • North America (Product, Application, End User)
    • US
    • Canada
  • Europe (Product, Application, End User)
    • Germany
    • Spain
    • France
    • UK
    • Italy
    • Rest of Europe
  • Asia Pacific (Product, Application, End User)
    • China
    • India
    • Japan
    • South Korea
    • Rest of Asia-Pacific
  • Latin America (Product, Application, End User)
    • Mexico
    • Brazil
    • Rest of Latin America
  • Middle East & Africa (Product, Application, End User)
    • GCC Countries
    • South Africa
    • Rest of Middle East & Africa

Competitive Intelligence

  • Top 5 Player Comparison
  • Market Positioning of Key Players, 2025
  • Strategies Adopted by Key Market Players
  • Recent Developments in the Market
  • Company Market Share Analysis, 2025
  • Company Profiles of All Key Players
    • Company Details
    • Product Portfolio Analysis
    • Company's Segmental Share Analysis
    • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

  • Medtronic Plc (Ireland)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Boston Scientific Corporation (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Cardiovascular Systems, Inc. (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Royal Philips (Netherlands)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Avinger, Inc. (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Terumo Corporation (Japan)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • AngioDynamics, Inc. (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Braun Group (Germany)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Abbott Laboratories (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • B. Braun Melsungen AG (Germany)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Biotronik SE & Co. KG (Germany)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Biomerics (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Philips (Netherlands)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Cook Medical, Inc. (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Cardinal Health, Inc. (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Rex Medical, L.P. (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • W. L. Gore & Associates, Inc. (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Minnetronix, Inc. (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Merit Medical Systems, Inc. (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • NexStep Medical (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments

Conclusion & Recommendations